ARCHIVES

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

March 3, 1989

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

December 5, 2014

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013